Rhumbline Advisers Makes New $221,000 Investment in Cibus, Inc. (NASDAQ:CBUS)

Rhumbline Advisers acquired a new stake in Cibus, Inc. (NASDAQ:CBUS) in the second quarter, according to its most recent filing with the SEC. The fund acquired 22,427 shares of the company’s stock, valued at approximately $221,000.

Separately, Vanguard Group Inc. grew its position in Cibus by 3.7% during the first quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock worth $16,215,000 after buying an additional 26,017 shares in the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.

Cibus Stock Down 1.8 %

Cibus stock opened at $3.35 on Friday. The company has a market cap of $72.18 million, a PE ratio of -0.18 and a beta of 1.84. Cibus, Inc. has a twelve month low of $3.33 and a twelve month high of $23.18. The company’s 50-day moving average price is $6.78 and its 200-day moving average price is $12.08.

Cibus (NASDAQ:CBUS) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.81) by ($0.33). Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. The company had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.44 million. During the same quarter in the previous year, the company posted ($3.05) earnings per share. As a group, sell-side analysts expect that Cibus, Inc. will post -3.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CBUS shares. Canaccord Genuity Group cut their price objective on Cibus from $21.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, September 19th. Canaccord Genuity Group raised shares of Cibus to a “strong-buy” rating in a research report on Friday, July 19th. Finally, Alliance Global Partners cut their price target on Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research note on Tuesday, September 24th.

Cibus Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.